Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI
Autor: | Laetitia Vanwonterghem, Jean-Luc Coll, Beatrice Eymin, Marie Guerard, Laurence David-Boudet, Sylvie Gazzeri, P. Perron, Anne-Sophie Hatat, Amandine Hurbin, Thomas Robin, Benoit Busser, Sylvie Lantuejoul |
---|---|
Přispěvatelé: | Team 'RNA splicing, cell signaling and response to therapies', Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Team 'Cancer targets and experimental therapeutics', Centre Hospitalier Universitaire [Grenoble] (CHU), Eymin, Beatrice, Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]) |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Cancer Research Lung Neoplasms [SDV]Life Sciences [q-bio] Apoptosis MESH: EGFR-TKI IGF1R Lung cancer Nuclear trafficking Resistance [SDV.BC]Life Sciences [q-bio]/Cellular Biology Amphiregulin Receptor tyrosine kinase Receptor IGF Type 1 03 medical and health sciences Gefitinib Epidermal growth factor Cell Line Tumor medicine Humans skin and connective tissue diseases Protein Kinase Inhibitors [SDV.BC] Life Sciences [q-bio]/Cellular Biology Insulin-like growth factor 1 receptor Cell Nucleus biology Chemistry Receptors Somatomedin Cell Cycle Checkpoints medicine.disease Adenocarcinoma Mucinous Xenograft Model Antitumor Assays respiratory tract diseases 3. Good health [SDV] Life Sciences [q-bio] body regions Protein Transport Cell nucleus 030104 developmental biology medicine.anatomical_structure Oncology A549 Cells Drug Resistance Neoplasm Cancer research biology.protein Signal transduction Signal Transduction medicine.drug |
Zdroj: | Cancer Letters Cancer Letters, 2018, 420, pp.146-155. ⟨10.1016/j.canlet.2018.01.080⟩ Cancer Letters, Elsevier, 2018, 420, pp.146-155. ⟨10.1016/j.canlet.2018.01.080⟩ |
ISSN: | 0304-3835 |
Popis: | International audience; Many Receptor Tyrosine Kinases translocate from the cell surface to the nucleus in normal and pathological conditions, including cancer. Here we report the nuclear expression of insulin-like growth factor-1 receptor (IGF1R) in primary human lung tumours. Using lung cancer cell lines and lung tumour xeno-grafts, we demonstrate that the epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) gefitinib induces the nuclear accumulation of IGF1R in mucinous lung adenocarcinoma by a mechanism involving the intracellular re-localization of the growth factor amphiregulin. Amphiregulin allows the binding of IGF1R to importin-b1 and promotes its nuclear transport. The nuclear accumulation of IGF1R by amphiregulin induces cell cycle arrest through p21 WAF1/CIP1 upregulation, and prevents the induction of apoptosis in response to gefitinib. These results identify amphiregulin as the first nuclear localization signal-containing protein that interacts with IGF1R and allows its nuclear translocation. Furthermore they indicate that nuclear expression of IGF1R contributes to EGFR-TKI resistance in lung cancer. |
Databáze: | OpenAIRE |
Externí odkaz: |